[VEGF].
Yoshiji
H
H
Third Department of Internal Medicine, Nara Medical University.
Fukui
H
H
Kuriyama
S
S
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D016228:Endothelial Growth Factors / Q000276:immunology / Q000502:physiology; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply / Q000473:pathology* / Q000628:therapy; D008222:Lymphokines / Q000276:immunology / Q000502:physiology; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology / Q000502:physiology; D017978:Receptors, Growth Factor / Q000276:immunology / Q000502:physiology; D040262:Receptors, Vascular Endothelial Growth Factor; D015398:Signal Transduction; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000906:Antibodies; D016228:Endothelial Growth Factors; D008222:Lymphokines; D017978:Receptors, Growth Factor; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D020794:Receptor Protein-Tyrosine Kinases; D040262:Receptors, Vascular Endothelial Growth Factor